交易 AbCellera Biologics Inc. - ABCL CFD
新增到我的最愛- 摘要
- 曆史數據
- 活動
- 盈虧控制
- 資産負債表
- 現金流
交易條件
價差 | 0.05 | ||||||||
多頭倉位隔夜費用
多頭隔夜費用
前往平台 | -0.026179% | ||||||||
空頭倉位隔夜費用
空頭隔夜費用
前往平台 | 0.003957% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 5% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 拋售 | 自訂 | 變化 (%) | 打開 | 最高 | 最小 |
---|---|---|---|---|---|---|
Apr 22, 2024 | 3.97 | 0.15 | 3.93% | 3.82 | 3.98 | 3.80 |
Apr 19, 2024 | 3.85 | 0.06 | 1.58% | 3.79 | 3.93 | 3.76 |
Apr 18, 2024 | 3.89 | 0.02 | 0.52% | 3.87 | 3.94 | 3.79 |
Apr 17, 2024 | 3.90 | -0.12 | -2.99% | 4.02 | 4.07 | 3.90 |
Apr 16, 2024 | 4.03 | -0.04 | -0.98% | 4.07 | 4.12 | 4.00 |
Apr 15, 2024 | 4.16 | -0.10 | -2.35% | 4.26 | 4.29 | 4.12 |
Apr 12, 2024 | 4.31 | 0.00 | 0.00% | 4.31 | 4.39 | 4.23 |
Apr 11, 2024 | 4.36 | -0.12 | -2.68% | 4.48 | 4.49 | 4.31 |
Apr 10, 2024 | 4.44 | 0.00 | 0.00% | 4.44 | 4.62 | 4.36 |
Apr 9, 2024 | 4.69 | 0.26 | 5.87% | 4.43 | 4.72 | 4.40 |
Apr 8, 2024 | 4.45 | 0.10 | 2.30% | 4.35 | 4.51 | 4.29 |
Apr 5, 2024 | 4.32 | 0.02 | 0.47% | 4.30 | 4.42 | 4.19 |
Apr 4, 2024 | 4.36 | 0.04 | 0.93% | 4.32 | 4.54 | 4.32 |
Apr 3, 2024 | 4.35 | 0.12 | 2.84% | 4.23 | 4.41 | 4.19 |
Apr 2, 2024 | 4.29 | -0.06 | -1.38% | 4.35 | 4.39 | 4.24 |
Apr 1, 2024 | 4.42 | -0.08 | -1.78% | 4.50 | 4.50 | 4.28 |
Mar 28, 2024 | 4.50 | -0.01 | -0.22% | 4.51 | 4.62 | 4.46 |
Mar 27, 2024 | 4.47 | 0.35 | 8.50% | 4.12 | 4.48 | 4.12 |
Mar 26, 2024 | 4.27 | -0.35 | -7.58% | 4.62 | 4.65 | 4.25 |
Mar 25, 2024 | 4.56 | 0.03 | 0.66% | 4.53 | 4.67 | 4.52 |
AbCellera Biologics Inc. Events
時間 (UTC) | 國家 | 事件 |
---|---|---|
Tuesday, May 7, 2024 | ||
時間 (UTC) 20:00 | 國家 US
| 事件 Q1 2024 Abcellera Biologics Inc Earnings Release Q1 2024 Abcellera Biologics Inc Earnings ReleaseForecast(預報) -返回 - |
時間 (UTC) 21:00 | 國家 US
| 事件 Q1 2024 Abcellera Biologics Inc Earnings Call Q1 2024 Abcellera Biologics Inc Earnings CallForecast(預報) -返回 - |
Friday, June 14, 2024 | ||
時間 (UTC) 16:00 | 國家 US
| 事件 Abcellera Biologics Inc Annual Shareholders Meeting Abcellera Biologics Inc Annual Shareholders MeetingForecast(預報) -返回 - |
Thursday, August 1, 2024 | ||
時間 (UTC) 20:00 | 國家 US
| 事件 Q2 2024 Abcellera Biologics Inc Earnings Release Q2 2024 Abcellera Biologics Inc Earnings ReleaseForecast(預報) -返回 - |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 485.424 | 375.203 | 233.155 | 11.6115 | 8.83056 |
收入 | 485.424 | 375.203 | 233.155 | 11.6115 | 8.83056 |
總營業費用 | 268.913 | 170.79 | 80.824 | 15.7285 | 9.58317 |
銷售/一般/行政費用,總計 | 66.755 | 48.761 | 15.752 | 4.01153 | 2.86219 |
研究與開發 | 107.879 | 62.062 | 29.393 | 10.1129 | 5.80252 |
Depreciation / Amortization | 27.843 | 14.451 | 4.836 | 1.60408 | 0.91846 |
營業收入 | 216.511 | 204.413 | 152.331 | -4.11701 | -0.75261 |
利息收入(費用),非經營淨值 | 12.034 | -2.75 | -2.818 | 0.13181 | -0.5325 |
其他,淨值 | 10.554 | 17.486 | 8.32 | 1.7745 | 1.59397 |
稅前淨收入 | 239.099 | 219.149 | 157.833 | -2.2107 | 0.30885 |
稅後淨收入 | 158.519 | 153.464 | 118.918 | -2.2107 | 0.30885 |
未計算非常項目前的淨收益 | 158.519 | 153.464 | 118.918 | -2.2107 | 0.30885 |
淨收入 | 158.519 | 153.464 | 118.918 | -2.2107 | 0.30885 |
Total Adjustments to Net Income | 0 | -0.01695 | |||
普通股股東可獲收益 (不含非經常性項目) | 158.519 | 153.464 | 118.918 | -2.2107 | 0.29191 |
普通股股東可獲收益 (含非經常性項目) | 158.519 | 153.464 | 118.918 | -2.2107 | 0.29191 |
攤薄淨收入 | 158.519 | 153.464 | 118.918 | -2.2107 | 0.29191 |
攤薄後加權平均股 | 314.827 | 318.294 | 269.498 | 265.565 | 265.565 |
扣除特別項目的每股攤薄盈利 | 0.50351 | 0.48215 | 0.44126 | -0.00832 | 0.0011 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | |||
每股正常攤薄盈利 | 0.50351 | 0.48215 | 0.4516 | -0.00832 | 0.0011 |
異常費用(收入) | 3.7 | ||||
Other Operating Expenses, Total | 66.436 | 45.516 | 27.143 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 10.056 | 12.192 | 21.545 | 101.383 | 45.917 |
收入 | 10.056 | 12.192 | 21.545 | 101.383 | 45.917 |
總營業費用 | 61.445 | 77.066 | 59.323 | 63.648 | 54.313 |
銷售/一般/行政費用,總計 | 19.362 | 18.905 | 15.706 | 16.881 | 17.532 |
研究與開發 | 36.473 | 52.647 | 28.245 | 26.582 | 26.685 |
Depreciation / Amortization | 5.61 | 5.514 | 13.818 | 5.15 | 4.886 |
Other Operating Expenses, Total | 0 | 0 | 1.554 | 15.035 | 5.21 |
營業收入 | -51.389 | -64.874 | -37.778 | 37.735 | -8.396 |
利息收入(費用),非經營淨值 | 10.779 | 9.759 | 12.034 | ||
其他,淨值 | 2.606 | 6.967 | -5.668 | 8.852 | 1.51 |
稅前淨收入 | -38.004 | -48.148 | -31.412 | 46.587 | -6.886 |
稅後淨收入 | -30.528 | -40.11 | -29.893 | 26.624 | -6.785 |
未計算非常項目前的淨收益 | -30.528 | -40.11 | -29.893 | 26.624 | -6.785 |
淨收入 | -30.528 | -40.11 | -29.893 | 26.624 | -6.785 |
普通股股東可獲收益 (不含非經常性項目) | -30.528 | -40.11 | -29.893 | 26.624 | -6.785 |
普通股股東可獲收益 (含非經常性項目) | -30.528 | -40.11 | -29.893 | 26.624 | -6.785 |
攤薄淨收入 | -30.528 | -40.11 | -29.893 | 26.624 | -6.785 |
攤薄後加權平均股 | 288.906 | 287.767 | 286.308 | 315.818 | 284.687 |
扣除特別項目的每股攤薄盈利 | -0.10567 | -0.13938 | -0.10441 | 0.0843 | -0.02383 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -0.10567 | -0.13938 | -0.10441 | 0.0843 | -0.02383 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 1025.49 | 929.8 | 813.325 | 12.6403 | 15.1622 |
現金和短期投資 | 886.485 | 722.977 | 595.019 | 9.67689 | 11.0399 |
現金等價物 | 386.535 | 476.142 | 594.116 | 7.55292 | 10.4443 |
短期投資 | 499.95 | 246.835 | 0.903 | 2.12397 | 0.59558 |
應收賬款總額,淨額 | 103.41 | 174.858 | 212.336 | 2.25386 | 3.57203 |
應收賬款 - 貿易,淨額 | 38.593 | 160.576 | 212.336 | 1.15256 | 0.80888 |
預付的費用 | 9.064 | 5.293 | 0.70959 | 0.55034 | |
總資産 | 1540.91 | 1318.57 | 1005.54 | 23.4881 | 21.4922 |
物業/廠房/設備,總計 - 淨額 | 217.255 | 111.616 | 17.923 | 8.47994 | 6.32994 |
物業/廠房/設備,總計 - 總額 | 235.73 | 121.442 | 23.509 | 11.6369 | 7.88282 |
累計折舊,總計 | -18.475 | -9.826 | -5.586 | -3.15696 | -1.55288 |
應收票據 - 長期 | 0 | 1.78302 | 0 | ||
其他長期資産,總計 | 46.331 | 30.642 | 8.388 | 0.58478 | 0 |
流動負債總額 | 118.32 | 120.676 | 103.49 | 7.89486 | 6.43338 |
Payable/Accrued | 14.828 | 14.924 | 7.13 | 1.64337 | 1.51822 |
預提費用 | 12.037 | 3.652 | 0.675 | 0.41914 | 0 |
應付票據/短期債務 | 0 | 0 | 0 | 0.38725 | 0 |
長期債務的當前部分/資本租賃 | 0.19 | 2.07973 | 2.53135 | ||
其他流動負債,總計 | 91.455 | 102.1 | 95.495 | 3.36537 | 2.38381 |
負債總額 | 307.63 | 292.836 | 175.028 | 13.2359 | 9.88297 |
長期債務總額 | 0 | 0 | 2.198 | 1.36314 | 0.91122 |
長期債務 | 2.198 | 1.36314 | 0.91122 | ||
其他負債,總計 | 156.132 | 134.79 | 43.179 | 3.97792 | 2.53837 |
股權 | 1233.28 | 1025.73 | 830.508 | 10.2521 | 11.6092 |
Preferred Stock - Non Redeemable, Net | 0 | 7.54585 | 7.55701 | ||
普通股 | 734.365 | 722.43 | 710.387 | 5.12175 | 5.07369 |
額外實收資本 | 74.118 | 35.357 | 5.919 | 2.30018 | 1.48344 |
留存收益(累計赤字) | 426.185 | 267.666 | 114.202 | -4.71563 | -2.50494 |
總負債和股東權益 | 1540.91 | 1318.57 | 1005.54 | 23.4881 | 21.4922 |
已發行普通股總數 | 286.852 | 283.257 | 269.498 | 265.565 | 265.565 |
其他流動資産,總計 | 25 | 25 | 5.97 | ||
商譽,淨額 | 47.806 | 47.806 | 31.5 | ||
無形資産,淨額 | 131.502 | 148.392 | 115.153 | ||
長期投資 | 72.522 | 50.313 | 19.247 | ||
遞延所得稅 | 33.178 | 37.37 | 26.161 | ||
總庫存 | 1.532 | 1.672 | |||
其他權益,總計 | -1.391 | 0.28 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
流動資産總額 | 919.518 | 930.735 | 940.653 | 1025.49 | 1045.67 |
現金和短期投資 | 785.84 | 795.694 | 796.495 | 886.485 | 868.206 |
現金等價物 | 172.422 | 179.747 | 193.017 | 386.535 | 371.973 |
應收賬款總額,淨額 | 75.483 | 86.233 | 99.569 | 103.41 | 105.964 |
應收賬款 - 貿易,淨額 | 37.446 | 45.678 | 20.003 | 38.593 | 105.964 |
總庫存 | 1.194 | 1.447 | 1.447 | 1.532 | |
預付的費用 | 32.001 | 22.361 | 18.142 | 9.064 | |
總資産 | 1512.19 | 1537.17 | 1497.92 | 1540.91 | 1552.41 |
物業/廠房/設備,總計 - 淨額 | 277.209 | 259.64 | 233.187 | 217.255 | 200.602 |
物業/廠房/設備,總計 - 總額 | 304.239 | 283.847 | 254.52 | 235.73 | 216.339 |
累計折舊,總計 | -27.03 | -24.207 | -21.333 | -18.475 | -15.737 |
商譽,淨額 | 47.806 | 47.806 | 47.806 | 47.806 | 47.806 |
無形資産,淨額 | 124.076 | 126.747 | 128.845 | 131.502 | 142.548 |
長期投資 | 62.887 | 58.792 | 57.583 | 72.522 | 66.718 |
其他長期資産,總計 | 80.694 | 113.446 | 89.845 | 46.331 | 49.066 |
流動負債總額 | 110.239 | 118.905 | 89.591 | 118.32 | 106.052 |
Payable/Accrued | 17.432 | 21.025 | 17.569 | 14.828 | 9.319 |
預提費用 | 11.923 | 9.812 | 7.66 | 12.037 | 28.084 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
長期債務的當前部分/資本租賃 | |||||
其他流動負債,總計 | 80.884 | 88.068 | 64.362 | 91.455 | 68.649 |
負債總額 | 329.415 | 342.339 | 289.419 | 307.63 | 302.237 |
長期債務總額 | 0 | 0 | 0 | 0 | 0 |
長期債務 | |||||
遞延所得稅 | 33.178 | 33.178 | 33.426 | 33.178 | 34.143 |
其他負債,總計 | 185.998 | 190.256 | 166.402 | 156.132 | 162.042 |
股權 | 1182.78 | 1194.83 | 1208.5 | 1233.28 | 1250.17 |
普通股 | 747.914 | 744.756 | 742.816 | 734.365 | 730.427 |
額外實收資本 | 109.384 | 96.423 | 81.63 | 74.118 | 64.384 |
留存收益(累計赤字) | 326.937 | 355.547 | 386.075 | 426.185 | 456.078 |
總負債和股東權益 | 1512.19 | 1537.17 | 1497.92 | 1540.91 | 1552.41 |
已發行普通股總數 | 289.778 | 289.189 | 288.427 | 286.852 | 285.762 |
其他權益,總計 | -1.46 | -1.899 | -2.021 | -1.391 | -0.717 |
其他流動資産,總計 | 25 | 25 | 25 | 25 | 71.499 |
短期投資 | 613.418 | 615.947 | 603.478 | 499.95 | 496.233 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
淨收入/起跑線 | 158.519 | 153.464 | 118.918 | -2.2107 | 0.30885 |
經營活動産生的現金 | 277.36 | 244.584 | 22.69 | 2.69372 | 3.56564 |
經營活動産生的現金 | 8.953 | 4.403 | 2.317 | 1.60408 | 0.91846 |
非現金物品 | 63.287 | 37.001 | 13.539 | 1.32723 | 0.42774 |
營運資金的變化 | 29.825 | 41.672 | -116.701 | 1.9731 | 1.91059 |
投資活動産生的現金 | -352.625 | -332.247 | -119.78 | -5.77991 | -5.30707 |
資本支出 | -72.66 | -58.452 | -14.673 | -3.99689 | -5.30707 |
其他投資現金流量項目,總計 | -279.965 | -273.795 | -105.107 | -1.78302 | 0 |
融資活動産生的現金 | -1.628 | -3.886 | 683.653 | 0.19483 | 12.1857 |
股票的發行(報廢),淨額 | 2.755 | 4.615 | 598.502 | 0.01416 | 10.2056 |
債務的發行(退還),淨額 | -0.323 | -0.951 | 85.151 | 0.18067 | 1.98015 |
現金淨變化 | -86.492 | -92.974 | 586.563 | -2.89137 | 10.4443 |
Amortization | 18.89 | 10.062 | 2.519 | ||
Deferred Taxes | -2.114 | -2.018 | 2.098 | ||
融資現金流項目 | -4.06 | -7.55 | |||
外彙效應 | -9.599 | -1.425 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -40.11 | 158.519 | 188.412 | 161.788 | 168.573 |
Cash From Operating Activities | -44.063 | 277.36 | 246.448 | 373.234 | 100.219 |
Cash From Operating Activities | 2.858 | 8.953 | 6.212 | 3.681 | 1.391 |
Amortization | 2.656 | 18.89 | 7.844 | 5.213 | 2.606 |
Deferred Taxes | -2.114 | ||||
Non-Cash Items | 13.446 | 63.287 | 43.148 | 26.226 | 12.675 |
Changes in Working Capital | -22.913 | 29.825 | 0.832 | 176.326 | -85.026 |
Cash From Investing Activities | -149.609 | -352.625 | -335.562 | -53.568 | -26.371 |
Capital Expenditures | -14.984 | -72.66 | -60.33 | -45.817 | -14.495 |
Other Investing Cash Flow Items, Total | -134.625 | -279.965 | -275.232 | -7.751 | -11.876 |
Cash From Financing Activities | -0.458 | -1.628 | -1.977 | -1.958 | -3.131 |
Financing Cash Flow Items | -0.948 | -4.06 | -4.06 | -4.06 | -5 |
Issuance (Retirement) of Stock, Net | 0.49 | 2.755 | 2.406 | 2.175 | 1.941 |
Issuance (Retirement) of Debt, Net | -0.323 | -0.323 | -0.073 | -0.072 | |
Foreign Exchange Effects | -0.213 | -9.599 | -9.963 | -1.411 | -0.204 |
Net Change in Cash | -194.343 | -86.492 | -101.054 | 316.297 | 70.513 |
差價合約交易計算器
計算您的假設損益
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
交易
交易規模(槓桿 x 投資):
打開
拋售
已賣出 做多
Industry: | Biotechnology & Medical Research (NEC) |
2215 Yukon Street
VANCOUVER
BRITISH COLUMBIA V5Y 0A1
CA
盈虧控制
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 610,000 多名交易者,選擇與 Capital.com 交易